We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The world already has a supersuccessful pneumococcal conjugate vaccine in Pfizer's Prevnar 13, but that isn't stopping PnuVax from pushing ahead with its own program.